| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |